Topic: Regeneron

Regeneron’s acquisition of 23andMe raises significant privacy concerns regarding the handling of personal DNA data. This move highlights the ongoing issues of data ownership and the potential for misuse by corporations, emphasizing the need for strong protections against surveillance and data exploitation. As companies increasingly collect sensitive information, the implications for individual privacy and free expression become more critical.